Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science ...

The latest price target for Becton Dickinson (NYSE:BDX) was reported by Citigroup on May 22, 2025. The analyst firm set a price target for $185.00 expecting BDX to rise to within 12 months (a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...